Aligos Therapeutics, Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-13.02 | $-15.97 |
| FY2020 | $-5.44 | $-11.28 |
| FY2021 | $-1.61 | $-8.14 |
| FY2022 | $-1.13 | $-6.41 |
| FY2023 | $-17.10 | $-8.65 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2019 | $-13.02 | $-15.97 |
| FY2020 | $-5.44 | $-11.28 |
| FY2021 | $-1.61 | $-8.14 |
| FY2022 | $-1.13 | $-6.41 |
| FY2023 | $-17.10 | $-8.65 |